Advertisement
    In the last 8 hours
    Peptide Purgatory: GLP-1 Muscle Loss In Depth The Nittany Turkey (Weblog)00:14
    Yesterday
    In the last 7 days
    GLP-1 Drugs Reshape Restaurant Menus DevX.com21:52 20-Jan-26
    Britain’s Mounjaro moment UnHerd01:12 20-Jan-26
    Triple-strength weight loss jab approved by MHRA Nursing in Practice11:55 19-Jan-26
    Prediction: 2026 Will Be the Year of Eli Lilly The Motley Fool10:33 19-Jan-26
    Medicaid Coverage of and Spending on GLP-1s The Henry J. Kaiser Family Foundation15:14 16-Jan-26
    In the last month
    JPM: NVIDIA Launches AI Collaborations with Eli Lilly, Thermo Fisher Genetic Engineering and Biotechnology News23:08 13-Jan-26
    Slimming injections linked to faster weight regain than traditional dieting National Institute for Health Research19:10 12-Jan-26
    Weight-loss drugs may also help prevent colon cancer Knowridge Science Report01:43 10-Jan-26
    Alveus debuts in obesity arena with $160m Series A Pharmaceutical Technology13:17 9-Jan-26
    These weight-loss drugs can help treat sleep apnea Knowridge Science Report11:39 9-Jan-26
    view more headlines
    22 Jan 00:14

    About our Tirzepatide news

    Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.